NASDAQ:NVCR

NovoCure Stock Still Up Ahead of Cancer Trial Data

NovoCure Stock Still Up Ahead of Cancer Trial Data

NovoCure shares closed at $17.96 Friday, up 0.3%, and slipped to $17.71 after hours ahead of the Memorial Day market closure. The stock remains about 50% above its April 29 close, after the company raised its 2026 revenue forecast and reported Q1 revenue of $174.1 million. NovoCure had 4,791 active patients at March’s end, including 83 on its new pancreatic cancer device.
May 24, 2026

Stock Market Today

  • Australian Farm Profits Plummet 70% Amid Drought and Rising Costs
    June 2, 2026, 1:56 AM EDT. Australian farmers face a steep 70% drop in profits, down to about AUD 65,000 per farm, as drought and soaring input costs bite, according to the Australian Bureau of Agricultural and Resource Economics and Sciences (ABARES). Winter crop production is set to fall 21%, slashing agricultural export value by AUD 7 billion. Wheat, the nation's largest grain export, is expected to decline 12% in planting area, the smallest since 2019-20, while barley plantings may rise 4% fueled by better prices. Canola and pulse crops see mixed forecasts with canola down 6%. Despite a 5% drop in total farm production to AUD 98 billion, ABARES notes resilience but warns of a challenging drier-than-average winter season ahead, especially in NSW and Queensland.